Abstract:Acute liver failure (ALF) requiring liver transplantation is a disease that occurs due to rapid hepatocellular dysfunction. As liver transplantation has various limitations, including donor scarcity, high cost, and immuno-incompatibility, continuous local delivery of biopharmaceuticals to the liver tissue can be a promising ALF treatment option. Here, the in vivo safety and usability of a 3D-printed implantable drug delivery device for effective ALF treatment is evaluated. The implantable reservoir consists of… Show more
“…3D printing has also been utilised for the production of personalised drug-eluting implants and medical devices [172][173][174][175]. For example, researchers have combined the use of scanners with 3D printing in order to create drug-eluting anti-acne masks, anatomically tailored wound dressings, mouthguards, and bespoke anti-biofilm multi drug-loaded hearing aids [128,[176][177][178].…”
Section: Patient-specific Prosthetics Implants and Medical Devicesmentioning
“…3D printing has also been utilised for the production of personalised drug-eluting implants and medical devices [172][173][174][175]. For example, researchers have combined the use of scanners with 3D printing in order to create drug-eluting anti-acne masks, anatomically tailored wound dressings, mouthguards, and bespoke anti-biofilm multi drug-loaded hearing aids [128,[176][177][178].…”
Section: Patient-specific Prosthetics Implants and Medical Devicesmentioning
“…Owing to its complex structure and function, the reconstruction of the liver is a major problem in the application of 3D printing technology in the field of organ transplantation. 109 In order to overcome these obstacles, various liver-on-a-chip models have been approved for in vitro liver drug testing. 110 With the help of bioprinting, Lee et al developed a three-dimensional liver-on-a-chip model, including different types of liver cells, liver ECM microenvironments, and vascular/biliary fluid tubes.…”
Section: The Advancement Of 3d Bioprinting In Organ Transplantationmentioning
“…The container in the reservoir was 3D printed which contains a semi-permeable membrane for administration of drugs. The study concluded that the system was safe for acute liver failure treatment and that various drugs could be administered via this 3D printed device [ 273 ]. Organ-on chip devices have gained a lot of traction these days for in-vitro studies of pathophysiological processes for drug screening.…”
Section: Applications Of 3d Bioprinting For Liver Diseasesmentioning
Fabrication of functional organs is the holy grail of tissue engineering and the possibilities of repairing a partial or complete liver to treat chronic liver disorders are discussed in this review. Liver is the largest gland in the human body and plays a responsible role in majority of metabolic function and processes. Chronic liver disease is one of the leading causes of death globally and the current treatment strategy of organ transplantation holds its own demerits. Hence there is a need to develop an in vitro liver model that mimics the native microenvironment. The developed model should be a reliable to understand the pathogenesis, screen drugs and assist to repair and replace the damaged liver. The three-dimensional bioprinting is a promising technology that recreates in vivo alike in vitro model for transplantation, which is the goal of tissue engineers. The technology has great potential due to its precise control and its ability to homogeneously distribute cells on all layers in a complex structure. This review gives an overview of liver tissue engineering with a special focus on 3D bioprinting and bioinks for liver disease modelling and drug screening.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.